Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Heron Therapeutics (HRTX)

Heron Therapeutics (HRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Heron Therapeutics 4242 CAMPUS POINT COURT SUITE 200 SAN DIEGO CA 92121 USA

P: 858-251-4400 F: 650-365-6490

Description:

Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.

Key Statistics

Overview:

Market Capitalization, $K 1,327,392
Shares Outstanding, K 90,855
Annual Sales, $ 145,970 K
Annual Net Income, $ -204,750 K
Last Quarter Sales, $ 22,670 K
Last Quarter Net Income, $ -55,190 K
60-Month Beta 1.79
% of Insider Shareholders 12.85%
% of Institutional Shareholders 96.49%
Float, K 79,180
% Float 87.15%

Growth:

1-Year Return -23.75%
3-Year Return -9.54%
5-Year Return -47.26%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 12.89%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.61 on 08/05/20
Next Earnings Date 11/10/20
Earnings Per Share ttm -2.25
EPS Growth vs. Prev Qtr -7.02%
EPS Growth vs. Prev Year 3.17%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-20 on 01/13/14

HRTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -14.58
Price/Earnings to Growth N/A
Return-on-Equity % -57.52%
Return-on-Assets % -43.64%
Profit Margin % -140.27
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 9.07
Price/Cash Flow N/A
Price/Book 4.09
Book Value/Share 3.57
Interest Coverage -138.29
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar